• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

32年间胃癌管理的趋势:一项基于法国人群的研究。

Trends in the management of gastric cancer over a 32-year period: a French population-based study.

作者信息

Herbreteau Elodie, Jooste Valérie, Hamza Samia, Lepage Côme, Faivre Jean, Bouvier Anne-Marie

机构信息

Digestive Cancer Registry of Burgundy INSERM U866, University Hospital, University of Burgundy, BP 87 900, 21079, Dijon Cedex, France.

出版信息

Gastric Cancer. 2015 Jan;18(1):129-37. doi: 10.1007/s10120-014-0342-6. Epub 2014 Feb 1.

DOI:10.1007/s10120-014-0342-6
PMID:24488016
Abstract

BACKGROUND

Gastric cancer is still generating interest because of its poor prognosis. The aim of this study was to investigate time trends in diagnostic assessment, patterns of care, and survival of gastric cancers.

METHODS

We considered 5,010 gastric cancers diagnosed between 1976 and 2007 in a well-defined French population. Logistic regressions were used to identify factors associated with R0 resection and operative mortality. A multivariate relative survival analysis was performed.

RESULTS

Diagnostic modalities have changed. Since 1988, endoscopy is performed when gastric cancer is suspected (95.5%). However, there has been no strong variation in stage over time: the proportion of stage I cancers increased from 5.5% to 13.4% between the periods 1976-1979 and 2004-2007 (p < 0.001) whereas that of advanced cases remained stable, 64.8% and 65.0%, respectively. R0 resections rose from 36.7% (1976-1979) to 46.7% between 1980 and 1999, and decreased to 32.7% thereafter. Age, tumor location, and period were associated with R0 resection. Neoadjuvant and adjuvant chemotherapy were rarely used before 2000, then reached 15.0% and 19.1%, respectively, during the later period. Operative mortality after R0 resection decreased from 18.3% during the 1976-1979 period to 4.3% during the 2004-2007 period (p < 0.001). Prognosis slightly improved during the three first periods, from 13.0% to 22.6%, then leveled off, not exceeding 26.0% thereafter. Stage, age, histology, and time period significantly influenced survival.

CONCLUSION

Changes in diagnostic modalities were associated with minor changes in stage and prognosis for gastric cancer. Earlier diagnosis and new therapeutic strategies are the best way to improve the prognosis.

摘要

背景

由于胃癌预后较差,其仍备受关注。本研究旨在调查胃癌诊断评估、治疗模式及生存情况的时间趋势。

方法

我们纳入了1976年至2007年间在法国一个明确界定的人群中诊断出的5010例胃癌患者。采用逻辑回归分析确定与R0切除及手术死亡率相关的因素。进行了多变量相对生存分析。

结果

诊断方式发生了变化。自1988年以来,怀疑患有胃癌时即进行内镜检查(95.5%)。然而,分期随时间变化不大:I期癌症的比例在1976 - 1979年期间至2004 - 2007年期间从5.5%增至13.4%(p < 0.001),而晚期病例的比例分别保持稳定,为64.8%和65.0%。R0切除率从1976 - 1979年的36.7%升至1980年至1999年期间的46.7%,此后降至32.7%。年龄、肿瘤位置和时期与R0切除相关。2000年前新辅助化疗和辅助化疗很少使用,后期分别达到15.0%和19.1%。R0切除术后的手术死亡率从1976 - 1979年期间的18.3%降至2004 - 2007年期间的4.3%(p < 0.001)。在最初三个时期预后略有改善,从13.0%升至22.6%,随后趋于平稳,此后未超过26.0%。分期、年龄、组织学类型和时期显著影响生存。

结论

诊断方式的改变与胃癌分期和预后的微小变化相关。早期诊断和新的治疗策略是改善预后的最佳途径。

相似文献

1
Trends in the management of gastric cancer over a 32-year period: a French population-based study.32年间胃癌管理的趋势:一项基于法国人群的研究。
Gastric Cancer. 2015 Jan;18(1):129-37. doi: 10.1007/s10120-014-0342-6. Epub 2014 Feb 1.
2
Population-based study of diagnosis, treatment and prognosis of gastric cancer.
Br J Surg. 1997 Oct;84(10):1474-8.
3
[Treatment and prognosis of stomach cancers in the population of the Cote d'Or's District (1976-1985)].[科多尔省地区人群胃癌的治疗与预后(1976 - 1985年)]
Bull Cancer. 1990;77(8):769-79.
4
Management and prognosis of esophageal cancers: has progress been made?食管癌的管理与预后:是否已取得进展?
Eur J Cancer. 2006 Jan;42(2):228-33. doi: 10.1016/j.ejca.2005.08.038. Epub 2005 Dec 7.
5
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.美国胃腺癌辅助和新辅助治疗的趋势和预测因素。
Ann Surg Oncol. 2013 Feb;20(2):362-70. doi: 10.1245/s10434-012-2552-7. Epub 2012 Aug 14.
6
[Utilization of multimodal therapy concepts in stomach carcinoma in Germany].[德国胃癌多模式治疗理念的应用]
Zentralbl Chir. 2000;125(4):341-7.
7
Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.围手术期化疗和根治性手术治疗胃癌患者的 ypT、ypN 和辅助治疗对生存的影响。
Ann Surg Oncol. 2019 Oct;26(11):3618-3626. doi: 10.1245/s10434-019-07454-0. Epub 2019 Jun 20.
8
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.使用内镜超声和腹腔镜超声对上消化道癌患者进行治疗前评估。
Dan Med J. 2012 Dec;59(12):B4568.
9
Neoadjuvant chemotherapy upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study.新辅助化疗联合手术治疗胃印戒细胞癌的回顾性倾向评分匹配研究。
World J Gastroenterol. 2020 Feb 28;26(8):818-827. doi: 10.3748/wjg.v26.i8.818.
10
Trends in the management and survival of digestive tract cancers among patients aged over 80 years.80岁以上患者消化道癌症的管理与生存趋势。
Aliment Pharmacol Ther. 2005 Aug 1;22(3):233-41. doi: 10.1111/j.1365-2036.2005.02559.x.

引用本文的文献

1
Effectiveness and safety of combined treatment with herbal medicines and palliative chemotherapy for advanced gastric cancer: A systematic review, and meta-analysis.草药与姑息化疗联合治疗晚期胃癌的有效性和安全性:一项系统评价与荟萃分析。
Integr Med Res. 2025 Mar;14(1):101098. doi: 10.1016/j.imr.2024.101098. Epub 2024 Nov 22.
2
Anti-Helicobacter pylori antibody status is associated with cancer mortality: A longitudinal analysis from the Japanese DAIKO prospective cohort study.抗幽门螺杆菌抗体状态与癌症死亡率相关:来自日本DAIKO前瞻性队列研究的纵向分析。
PLOS Glob Public Health. 2023 Feb 8;3(2):e0001125. doi: 10.1371/journal.pgph.0001125. eCollection 2023.
3

本文引用的文献

1
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands.1990 年至 2007 年期间胃腺癌发病率、治疗和生存趋势:荷兰基于人群的研究。
Eur J Cancer. 2010 Apr;46(6):1101-10. doi: 10.1016/j.ejca.2010.02.013. Epub 2010 Mar 8.
2
What reasons lie behind long-term survival differences for gastric cancer within Europe?是什么原因导致欧洲地区胃癌患者的长期生存率存在差异?
Eur J Cancer. 2010 Apr;46(6):1086-92. doi: 10.1016/j.ejca.2010.01.019. Epub 2010 Feb 15.
3
Perspectives in adjuvant therapy of gastric cancer.
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.
晚期胃或胃食管结合部腺癌化疗的日常实践:METESTOMAC 法国前瞻性队列研究。
Cancer Med. 2023 Mar;12(5):5341-5351. doi: 10.1002/cam4.5354. Epub 2022 Nov 16.
4
Clinicopathological Prognostic Factors Determining Outcomes of Treatment in Gastric Cancer Surgery.胃癌手术治疗结局的临床病理预后因素。
In Vivo. 2022 Nov-Dec;36(6):2927-2935. doi: 10.21873/invivo.13035.
5
Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.加拿大安大略省食管癌和胃癌姑息性放疗:基于人群的应用模式和结局。
J Palliat Care. 2023 Apr;38(2):157-166. doi: 10.1177/08258597211072946. Epub 2022 Jan 19.
6
Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario.安大略省接受手术切除的非转移性胃癌患者手术治疗模式和治疗结果的地域差异。
Curr Oncol. 2018 Oct;25(5):e436-e443. doi: 10.3747/co.25.3953. Epub 2018 Oct 31.
7
Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach.结肠癌相关转录本-1(CCAT1)在胃腺癌中的表达
J Cancer. 2015 Jan 1;6(2):105-10. doi: 10.7150/jca.10568. eCollection 2015.
胃癌辅助治疗的观点。
Oncology. 2009;77 Suppl 1:38-42. doi: 10.1159/000258494. Epub 2010 Feb 2.
4
Operative mortality after gastric cancer resection and long-term survival differences across Europe.欧洲胃癌切除术术后死亡率与长期生存差异。
Br J Surg. 2010 Feb;97(2):235-9. doi: 10.1002/bjs.6865.
5
Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.印戒细胞组织学是胃腺癌不良预后的独立预测因子,与肿瘤的临床表现无关。
Ann Surg. 2009 Dec;250(6):878-87. doi: 10.1097/SLA.0b013e3181b21c7b.
6
Survival trends in European cancer patients diagnosed from 1988 to 1999.1988年至1999年确诊的欧洲癌症患者的生存趋势。
Eur J Cancer. 2009 Apr;45(6):1042-66. doi: 10.1016/j.ejca.2008.11.029. Epub 2009 Jan 3.
7
Cancer incidence and mortality in France over the period 1980-2005.1980年至2005年期间法国的癌症发病率和死亡率。
Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-175. doi: 10.1016/j.respe.2008.03.117. Epub 2008 Jun 10.
8
Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.美国非贲门胃癌胃切除术的使用、质量及治疗结果的长期趋势。
Ann Surg Oncol. 2007 Sep;14(9):2519-27. doi: 10.1245/s10434-007-9386-8. Epub 2007 Jul 3.
9
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.可切除的胃食管癌围手术期化疗与单纯手术治疗的比较
N Engl J Med. 2006 Jul 6;355(1):11-20. doi: 10.1056/NEJMoa055531.
10
Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995.1984年至1995年间法国菲尼斯泰尔地区胃癌的流行病学及长期生存率
Gastroenterol Clin Biol. 2005 Jan;29(1):23-32. doi: 10.1016/s0399-8320(05)80690-6.